MRNA
Moderna insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$203.21
+637.9% over 12 months
Share price and insider trades
MRNA closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$64.6M
Insiders buying0
Insiders selling6
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Moderna insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $64.6M. 17 of 19 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 132 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | Stephen HogePresident | Sell Plan | 40,281 | $146.07 | $5.9M | +39.1% | — |
| Sep 16SEC | Stephen HogePresident | Sell Plan | 40,294 | $144.13 | $5.8M | +41.0% | — |
| Sep 14SEC | James M MockCFO | Sell Plan | 19,836 | $134.49 | $2.7M | +51.1% | — |
| Sep 14SEC | James M MockCFO | Sell Plan | 15,000 | $134.49 | $2.0M | +51.1% | — |
| Sep 3SEC | Shannon Thyme KlingerGeneral Counsel | Sell Plan | 3,471 | $139.95 | $486K | +45.2% | — |
| Aug 7SEC | Stephane BancelCEO | Sell Plan | 187,044 | $58.79 | $11.0M | +245.7% | — |
| Aug 7SEC | Stephane BancelCEO | Sell Plan | 147,473 | $56.21 | $8.3M | +261.5% | — |
| Aug 7SEC | Stephane BancelCEO | Sell Plan | 124,838 | $56.96 | $7.1M | +256.8% | — |
| Aug 7SEC | Stephane BancelCEO | Sell Plan | 39,891 | $58.12 | $2.3M | +249.6% | — |
| Jul 16SEC | Stephen HogePresident | Sell Plan | 53,336 | $67.60 | $3.6M | +200.6% | — |
| Jun 17SEC | Stephen HogePresident | Sell Plan | 53,336 | $51.37 | $2.7M | +295.6% | — |
| Jun 8SEC | Shannon Thyme KlingerGeneral Counsel | Sell Plan | 3,471 | $50.00 | $174K | +306.4% | — |
| May 22SEC | Noubar AfeyanDirector | Sell | 9,263 | $46.84 | $434K | +333.8% | — |
| May 18SEC | Stephen HogePresident | Sell Plan | 53,336 | $48.40 | $2.6M | +319.9% | — |
| May 4SEC | Abbas HussainDirector | Sell Plan | 5,682 | $46.63 | $265K | +335.8% | — |
| Mar 3SEC | Shannon Thyme KlingerGeneral Counsel | Sell Plan | 13,885 | $52.29 | $726K | +288.6% | — |
| Feb 25SEC | Stephen HogePresident | Sell Plan | 160,009 | $48.84 | $7.8M | +316.1% | — |
| Dec 15SEC | Noubar AfeyanDirector | Sell | 23,853 | $29.48 | $703K | +589.2% | — |
| Dec 11SEC | Abbas HussainDirector | Sell Plan | 504 | $27.60 | $14K | +636.3% | — |
Insiders at Moderna
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Stephane BancelCEO | — | $28.7M | Aug 7, 2026 | — |
| Stephen HogePresident | — | $28.4M | Sep 16, 2026 | — |
| James M MockCFO | — | $4.7M | Sep 14, 2026 | — |
| Shannon Thyme KlingerGeneral Counsel | — | $1.4M | Sep 8, 2026 | — |
| Noubar AfeyanDirector | — | $1.1M | May 22, 2026 | — |
| Abbas HussainDirector | — | $279K | May 4, 2026 | — |
| Elizabeth E TallettDirector | — | — | May 4, 2026 | — |
| Francois NaderDirector | — | — | May 4, 2026 | — |
| Elizabeth G NabelDirector | — | — | May 4, 2026 | — |
| David M. RubensteinDirector | — | — | May 4, 2026 | — |
| Sandra HorningDirector | — | — | May 4, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about MRNA insiders
Are Moderna insiders buying MRNA stock?
In the past 12 months, 0 insiders reported open-market purchases of MRNA worth $0.
Are Moderna insiders selling MRNA stock?
6 insiders reported sales worth $64.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.